- Science of Glycochemistry
- GlycoSMART
- Product Pipeline
- Publications
Product Pipeline
Original and efficient candidates with proof of concept
CarboMimetics brings an original and efficient solution through its total synthesis expertise.
THERAPEUTIC DEVELOPMENT PROGRAM: NEUTRALIZABLE ANTI-THROMBOTIC
*ECC: extracorporeal blood circuit during cardiac surgery, or during extracorporeal membrane oxygenation, or during circulatory assistance
CM20161 & CM20201 : Neutralizable & selective FXa anticoagulants
CM30256 : Neutralizable dual factor Xa inhibitor/ glycoprotein IIbIIIa antagonist
THERAPEUTIC DEVELOPMENT PROGRAM: ONCOLOGY
COSMETIC DEVELOPMENT PROGRAM: ANTI-AGING
Extensive research and development in CarboMimetics’s lab remain underway to build a new collection of original oligosaccharides, small sugar fragments derived from natural polysaccharides found in plants, seaweeds, fungi and bacteria.
These fragments will be a potential target for therapeutic (including adjuvants for vaccines in veternary and human heathcare), cosmetic and dermocosmetic areas.
A new original collection of oligosaccharides is available for in vitro testing for lead determination on many biological targets and primary evaluations on cytokines, chemokines and proteases have shown promising results.
If you are interested to our original oligosaccharides collection for R&D partnership, please contact us.